ABSTRACT The processing of asparagine-linked oligosaccharides on the a-chains of an immunoglobulin A (IgA) has been investigated using MOPC 315 murine plasmacytoma cells . These cells secrete IgA containing complex-type oligosaccharides that were not sensitive to endo-ß-N-acetylglucosaminidase H. In contrast, oligosaccharides present on the intracellular a-chain precursor were of the high mannose-type, remaining sensitive to endo-ß-N-acetylglucosaminidase H despite a long intracellular half-life of 2-3 h . The major [3 H]mannose-labeled a-chain oligosaccharides identified after a 20-min pulse were ManSGIcNAC 2 and Man9GIcNAc 2. Following chase incubations, the major oligosaccharide accumulating intracellularly was Man 6GIcNAc 2, which was shown to contain a single al,2-linked mannose residue . Conversion of Man 6GIcNAc 2 to complex-type oligosaccharides occurred at the time of secretion since appreciable amounts of Man SGIcNAC2 or further processed structures could not be detected intracellularly. The subcellular locations of the al,2-mannosidase activities were studied using carbonyl cyanide m-chlorophenylhydrazone and monensin . Despite inhibiting the secretion of IgA, these inhibitors of protein migration did not effect the initial processing of Man9GIcNAc2 to Man 6GIcNAc 2. Furthermore, no large accumulation of Man SGIcNAC2 occurred, indicating the presence of two subcellular locations of al,2-mannosidase activity involved in oligosaccharide processing in MOPC 315 cells. Thus, the first three al,2-linked mannose residues were removed shortly after the a-chain was glycosylated, most likely in rough endoplasmic reticulum, since this processing occurred in the presence of carbonyl cyanide m-chlorophenylhydrazone. However, the removal of the final al,2-linked mannose residue as well as subsequent carbohydrate processing occurred just before IgA secretion, most likely in the trans Golgi complex since processing of Man 6GIcNAc 2 to Man SGIcNAC2 was greatly inhibited in the presence of monensin .
A number of membrane, lysosomal, and secretory glycoproteins have been studied to define the subcellular location of the carbohydrate modifications required to form complextype asparagine-linked oligosaccharide chains . It is known that the biosynthesis of the N-linked complex-type oligosaccharides of proteins involves the transfer ofa high molecular weight oligosaccharide containing glucose, mannose, and Nacetylglucosamine from dolichol diphosphate to asparagine residues in the protein (1) . Once transferred to protein, oligosaccharides destined to become complex-type are processed extensively. The terminal glucose residues are removed rap-THE JOURNAL OF CELL BIOLOGY " VOLUME 98 FEBRUARY 1984 407-416 0 The Rockefeller University Press -0021-9525/84/98/0407/10 $1 .00 idly by specific membrane-bound glucosidases thought to be located in the rough and smooth endoplasmic reticulum (2) (3) (4) . Subsequently, the four al,2-linked mannose residues are removed by one or more specific a1,2-mannosidases . There is evidence indicating that this initial mannose processing could occur in the Golgi apparatus since enzymes capable of removing these a1,2-linked mannose residues have been isolated from purified rat liver Golgi membranes (5, 6) . The Golgi apparatus is also the major subcellular location of the enzymes responsible for further carbohydrate modifications . These enzymes include the N-acetylglucosaminyltransferase, which attaches an N-acetylglucosamine residue to a Man5GlcNAc2 species (5, 7, 8) , a-mannosidase II, which acts on G1cNAcMan5GlcNAc2 to remove the terminal a1,3-linked and a1,6-linked mannose residues to form GIcNAcMan3GlcNAc2 (5) (6) (7) (8) , and the glycosyltransferases that are involved in the elongation of the complex-type oligosaccharides.
Despite the isolation and partial purification of presumed processing a-mannosidases from rat Golgi membranes, others studying different cell types have suggested that the enzymatic removal of mannose residues occurs, at least in part, in the rough endoplasmic reticulum. For example, Tartakoff and Vassalli (9) have shown that trimming of mannose residues from IgM u-chain oligosaccharides occurs in mouse plasmablasts even in the presence of carboxyl cyanide m-chlorophenylhydrazone (CCCP)', an uncoupler of oxidative phosphorylation known to inhibit intracellular protein migration from the rough endoplasmic reticulum (10) . In contrast,
Godelaine et al. (11) have suggested that only a single a1,2-linked mannose is removed in the rough endoplasmic reticulum of calfthyroid cells, since they observed the accumulation of thyroglobulin-linked Man8GlcNAc2 in thyroid slices labeled for 1 h and chased in the presence of CCCP. Hakimi and Atkinson (12) also concluded that one a 1,2-linked mannose residue is removed from the Sindbis virus proteins B and PE2 in the rough endoplasmic reticulum ofchick embryo
fibroblasts. An a1,2-mannosidase has recently been partially purified from the rough endoplasmic reticulum of rat liver cells (13) .
In view of these findings, we have examined the processing of immunoglobulin A (IgA) a-chain (heavy chain) oligosaccharides isolated from MOPC 315 plasmacytoma cells. In this study, we present evidence of at least two distinct subcellular locations of a1,2-mannosidase activity involved in the processing of IgA a-chain oligosaccharides . Processing a1,2-mannosidase activity appears to be present in the endoplasmic reticulum and the trans Golgi complex of these cells. Baenziger (Washington University School of Medicine). 3a70 scintillation fluid and TS-1 were obtained from Research Products International Corp ., Mt. Prospect, IL.
MATERIALS AND METHODS
Plasmacytorna Line : The IgA-secreting MOPC 315/J cells that were established in suspension culture from MOPC 315 ascites tumor cells were provided by Dr . Richard Lynch (Department of Pathology, University of Iowa). The cells were maintained as suspension cultures in L-15 medium containing 10% fetal calf serum, 100 U/ml of penicillin, and 100 pg/ml of streptomycin . This cell line has a doubling time of -24 h at 37°C and was kept at a density of 3 x 10' to 1 .2 x 106 cells/ml by feeding and diluting every 48 h.
Incorporation of L-[3 H]Leucine into MOPC 3151gA: MOPC 315 plasmacytoma cells (8.0 x 10') were washed and incubated in 20 ml of leucinedeficient Eagle's minimal essential medium containing 10% fetal calf serum, penicillin, and streptomycin . L-['H]Leucine (400 pCi) was added to the culture and the cells were incubated at 37°C in a 9% C02 atmosphere. After 5 h, the cells were centrifuged at 800 g for 5 min in a Beckman Model TJ-6 centrifuge (Beckman Instruments, Spinco Div., Palo Alto, CA). The supernatant medium was carefully removed from the cell pellet and saved. The cell pellet was washed with 20 ml of ice-cold L-15 medium and solubilized for 30 min in 0.5% NP-40 (vol/vol) containing 0.0015 M MgC12 and 0.002 M phenylmethylsulfonylfluoride . The lysate was spun for 20 min at 12,000 g in a Brinkmann Eppendorf centrifuge 5412 (Brinkmann Instruments, Inc., Westbury, NY) and the supernatant solution saved for subsequent analysis.
Analysis of ['H]Leucine Labeled a-Chains Treated with
Endo-ß-N-Acetylglucosaminidase H: 0.4 ml of the cell medium containing 0.002 M phenylmethylsulfonylfluoride and 0.2 ml of the NP-40 cell lysate were adjusted to pH 5 with the addition of 0.05 ml of 1 M sodium citrate buffer. Endo-#-N-acetylglucosaminidase H (0 .002 U) was then added to each, and the samples were incubated under a toluene atmosphere in a 37°C water bath. Control samples containing the citrate buffer but no enzyme were also incubated . After 18 h, the samples were spun at 800 g for 10 min.
The biosynthetically labeled IgA was isolated by immunoprecipitation using a modification of the method described previously (14) . Cell lysates and medium containing cell secretions were incubated with goat anti-MOPC 315 IgA (20 gl/ml) for75 min at 4°C. SaCl (200,uI/ml) wasadded and theincubation continued at 4°C for another 45 min. The SaCI was then collected by centrifugation at 12,000 g and washed twice with ice-cold 0.15 M NaCl, 0.01 M Tris/ HCI, pH 7.4 .
The immune precipitates isolated on SaCI were eluted by boiling in 40 ,uI of electrophoresis sample buffer consisting of 0.0625 M Tris/HCI, pH 6.8, 5% 2-mercaptoethanol, 2% SDS, 10% glycerol, and 0.0002% bromophenol blue . Analysis of ['H]leucine-labeled a-chains by SDS PAGE was done using 7.5% acrylamide slab resolving gels according to the procedure of Laemmli (15) . Fluorography was performed with Kodak XR-5 film following the procedure of Bonner and Laskey (16) .
Pulse Labeling of MOPC 315 Cells with [3 H]Mannose :
MOPC 315 cells (8-12 x 10') were washed and suspended in 2-3 ml of 0.01 M sodium phosphate, 0.15 M NaCl, pH 7.4 buffer at 37°C. ['H]Mannose (200-250 pCi/ml) was added and the incubation continued for 20 min at 37°C . The pulse was stopped by the addition of 20 ml of ice-cold L 15 medium . The cells were washed once, and those to be chased were suspended in L,15 medium with 10% fetal calf serum at a density of 1 .5-2 .5 x 100 cells/ml. At the indicated times, portions of the chase cultures were removed for the isolation of intracellular IgA by immunoprecipitation. Cells were lysed as described above, except that the NP-40 lysis buffer contained 0.1 M mannose and 0.05 M glucose-6-phosphate. Analysis of the immunoprecipitates by SDS gel electrophoresis, as described, revealed the presence of a single band or doublet of radioactivity corresponding to the a-chain of IgA.
In some ['H]mannose or ['H]leucine pulse-chase experiments, monensin or CCCP was added to the cells at the completion of the pulse and included in the chase incubations. The final medium concentrations of 10 kM monensin or 50 kM CCCP were obtained by adding concentrated stock solutions of these compounds freshly dissolved in ethanol . This resulted in a final medium concentration of 0.25% ethanol . Cells incubated in medium containing 0.25% ethanol were used as controls. Neither monensin or CCCP had an effect on cell viability as determined by trypan blue dye exclusion. 12, 24 , and 36 h and the reactions were stopped by placing the digestion tubes in boiling water for 2 min. The pronase digests were then subjected to gel filtration on a column (1 .5 x 95 cm) of Bio-Gel P-6 equilibrated and eluted with 0.1 M NH4HC03, pH 8 .0. 1 ml fractions were collected and portions of these were analyzed for radioactivity in a Tracor Mark III liquid scintillation counter (Tracor Analytic, Inc ., Elk Grove Village, IL) after the addition of 3x70 scintillation fluid . Radioactive peaks were pooled as indicated, concentrated by lyophilization, treated with endo-#-N-acetylglucosaminidase H, and analyzed again on the Bio-Gel P-6 column . The reductions were stopped by the addition of 15 AI of glacial acetic acid. I ml of methanol was added and methyl borate was removed by repeated methanol additions and evaporations under vacuum . The ['H]mannose-labeled oligosaccharide alcohols were desalted od Bio-Gel P-2 or amberlite MB-3 and analyzed by HPLC . Methods used for HPLC were those described by Mellis and Baenziger (l7) using a 4 mm x 30 cm MicroPax AX-10 column (Varian Associates, Inc ., Palo Alto, CA) and a Varian Liquid Chromatography Model 5000 . Columns were run at a flow rate of l ml/min . The initial solvent was acetonitrile/H20 (65 :35) and the oligosaccharides were eluted by increasing the H 2O content at 0 .5%/min. Fractions were collected in scintillation vials at 0 .3-min intervals. Radioactivity was determined after the addition of 0.15 ml of H 2O and 3 .8 ml of 3x70. Elution profiles of standards were highly reproducible although they changed with repeated use of a column over a period of several months. Therefore, appropriate oligosaccharide alcohol standards were run on each day on which samples were analyzed .
Paper Chromatography Analyses : Descending paper chromatography was done with Whatman No. 1 paper (Whatman Laboratory Products, Inc ., Clifton, NJ) . To establish that the radioactivity incorporated into the labeled compounds was mannose, we hydrolyzed portions of various oligosaccharides in 2 N H2S0 4 for 5 h at 100°C, desalted, and subjected them to descending paper chromatography using solvent A, l-butanol/ethanol/H20 (10 :1 :2). Jack bean a-mannosidase digestions were analyzed using solvent B consisting of ethyl acetate/pyridine/H20/acetic acid (5 :5 :3 :1) . 1 cm strips of the dried chromatograms were soaked in 0 .15 M of H2O in scintillation vials and analyzed for radioactivity after the addition of 3.8 ml of 3x70 scintillation fluid .
RESULTS

Effects of Endo-ß-N-Acetylglucosaminidase H Treatment on the Electrophoresis of Intracellular and Secreted [3 H]Leucine-labeled IgA a-Chains
The IgA-secreting MOPC 315 cell line was chosen for study since it is known to secrete large amounts of a single IgA glycoprotein . Previous studies using pulse-chase experiments have shown that the secretion of newly synthesized IgA from these cells is relatively slow, with -50% of radiolabeled MOPC 315 IgA being secreted during the 2-3 h after pulse labeling (10, 14) . Experiments therefore were designed to define the time course of oligosaccharide processing . The enzyme endo-ß-N-acetylglucosaminidase H was used to determine whether a significant pool of processed a-chains accumulated intracellularly before secretion . apparent molecular weights (Fig. 1 a) . This electrophoretic pattern of murine a-chains has been described previously (18) . The heterogeneity appears to be the result of carbohydrate content since subsequent analysis after the treatment with endo-ß-N-acetylglucosaminidase H resulted in the appearance of a single band of radioactivity (Fig. I b) . The treated intracellular a-chains have a more rapid electrophoretic migration identical to that of nonglycosylated 0-chains synthesized in the presence of tunicamycin. The fact that the entire intracellular pool of a-chains was susceptible to the activity of endo-ß-N-acetylglucosaminidase H indicates that oligosaccharide processing is not complete until the time of secretion . This intracellular susceptibility is not complete until the time of secretion . This susceptibility of the intracellular a-chains to endo-ß-N-acetylglucosaminidase H is like that described for murine IgM u-chains (9) and human chorionic gonadotropin (19) .
In contrast to intracellular a-chains, the SDS PAGE migra-tion of secreted IgA a-chains was not affected by treatment with endo-ß-N-acetylglucosaminidase H, consistent with the presence of predominantly complex-type oligosaccharide units.
Analysis of Intracellular [3H]Mannose-labeled aChain Glycopeptides
Further experiments with endo-ß-N-acetylglucosaminidase H were performed to confirm that the changes in electrophoretic migration ofthe intact intracellular a-chains were in fact the result of the removal of high mannose-type oligosaccharide units . Fig. 2 shows the Bio-Gel P-6 elution profile of [3H]mannose pulse-labeled a-chain glycopeptides immunoprecipitated immediately at the conclusion of the pulse and after 51/2 h of chase incubation . Two major peaks of radioactivity were observed at both time points (Fig. 2, a and c) , each of which was susceptible to endo-#-N-acetylglucosaminidase H treatment as indicated by the change in gel filtration elution shown in Fig. 2, b and d. Thus, glycopeptides derived from pulse-labeled a-chains chased for 5'/2 h remained susceptible to endo-R-N-acetylglucosaminidase H, a result consistent with the data shown in Fig. 1 . This demonstrates that the carbohydrate processing of intracellular a-chains is not complete even after prolonged periods of time and that the final processing events must occur rapidly at the time of secretion, since no intracellular a-chain glycopeptides resistant to endo-ß-Nacetylglucosaminidase H could be identified . The two major glycopeptide peaks identified by gel filtration contain oligosaccharides ofsimilar size as determined by gel filtration ( Characterization of Endo-ß-NAcetylglucosarninidase H Released aChain Oligosaccha rides Fig. 3 shows the elution pattern of pulse-labeled intracellular a-chain oligosaccharide alcohols. The two major glycopeptide peaks isolated by gel filtration (Fig. 2 a) had identical oligosaccharide structuresthat eluted from the HPLC column in fractions identical to the known standards Man6GlcitoINAc, Man7GICitoINAC, Man8GIcitoINAc, and Man9GlcitolNAc. Since we have observed identical structures in both glycopeptide peaks in all experiments and at all time points, subsequent data has been derived from the larger of the two peaks corresponding to peaks 1 and IA ofFig. 2. Acid hydrolysis of intracellular oligosaccharides and subsequent paper chromatography in solvent A resulted in a single peak of radioactivity corresponding to mannose (data not shown) .
At the conclusion ofthe 20-min pulse, few oligosaccharides containing glucose could be identified. A small amount of radioactivity that eluted with the standard GlcMan9GlcitolNAc was seen as a shoulder present on the large Man9GlcitolNAc peak (Fig. 3 ). An even larger percentage (~50%) of glucosylated oligosaccharides was observed in a short 3-min pulse experiment (data not shown) . This indicates that glucose-containing oligosaccharides are transferred to achains and is consistent with previous findings that the terminal glucose residues are rapidly removed following transfer of the oligosaccharides from lipid to protein (1) . Further characterization of the 20-min pulse-labeled a-chain oligosaccharides was obtained by measuring the susceptibility of these structures to the exoglycosidase jack bean a-mannosidase. Fig. 4 shows the analysis by paper chromatography in solvent B of a jack bean a-mannosidase digestion revealing a large peak ofradioactivity that co-migrated with free mannose and a smaller peak of radioactivity with a migration similar to that of ManßGlcitolNAc . A very small peak of radioactivity was observed near the origin of the chromatogram shown in Fig. 4 . This a-mannosidase-resistant material was tentatively identified as G1c,Man4GlcitoINAc by comparison to the migration of known standards and most likely was derived from the small shoulder of glucosylated oligosaccharides detected by HPLC (Fig. 3) . Fig. 3 also shows the presence of pulse-labeled a-chain oligosaccharides containing less than nine mannose residues . A sizable portion ofthe HPLC-characterized oligosaccharides obtained at the conclusion of a 20-min pulse eluted in a position similar to that ofthe standard Man8GlcitolNAc. The proportion of Man8GlcitolNAc relative to Man9GlcitolNAc varied from 38 to 70% in several 15-to 20-min pulse-labeling experiments (data not shown) . In addition, lesser amounts of labeled structures judged by HPLC to be Man7GICitolNAC and Man6GlcitolNAc were also identified . We cannot exclude the possibility that small amounts of these structures are transferred directly to a-chains . However, the presence of the much higher percentage of glucosylated structures identified after a shorter 3-min pulse indicates that most ofthese oligosaccharides are derived from a larger glucosylated precursor. Thus, the removal of some al,2-linked mannose residues begins soon after glycosylation of a-chains despite the relatively long intracellular half-life ofthis glycoprotein.
The intracellular oligosaccharides present after 1, 3, and 5'/2 h of chase incubation of pulse-labeled a-chains are shown in Fig. 5 . By 1 h, the predominant peak ofradioactivity identified by HPLC was Man6GlcitolNAc, although >50% of the radioactivity was still present in peaks identified as Man8GlcitolNAc and Man9GlcitolNAc. No glucosylated oligosaccharides were identified by HPLC, and no jack bean amannosidase-resistant structures were observed by paper chromatography analyses (data not shown). After 3 h ofchase incubation, at a time when -50% of the pulse-labeled IgA has been secreted, there was a relative increase of Man6GlcNAc2 on the remaining intracellular a-chains . At 5'/2 h, the major oligosaccharide alcohol identified by HPLC was Man6GlcitolNAc. Only small amounts of Man7GlcitoINAc, Man8GlcitolNAc, and Man9GlcitolNAc could be identified. No further processing ofthe Man6GlcNAc2 could be detected even after this long chase incubation . No pools of smaller oligosaccharides were found, suggesting that the subsequent processing ofMan6GlcNAc2 must be closely coupled to secretion of the glycoprotein.
Effect of CCCP and Monensin on the Processing of IgA a-Chain Oligosaccharides
The above experiments are consistent with the presence of glycoprotein processing a1,2-mannosidase activity in two different subeellular locations since the removal of the final a1,2-linked mannose residue was closely associated with late processing enzymes such as N-acetylglucosaminyl transferase I, a-mannosidase II, and other glycosyltransferases thought to be located in the trans Golgi complex (20, 21) . CCCP and monensin were used, therefore, in an attempt to define further the subcellular sites of a1,2-mannosidase activity . CCCP has been shown to block the intracellular migration of immunoglobulins at the level of the rough endoplasmic reticulum, whereas monensin blocks within the Golgi apparatus (10). Initially, pulse-chase experiments were performed to determine whether these agents blocked the secretion of the MOPC 315 IgA. As shown in Fig. 6 , the presence of either CCCP or monensin in the chase medium inhibited the secretion of 315 IgA during the 5 h after pulse labeling with ['H]leucine . This inhibition of secretion was not the result of increased intracellular degradation, as determined by immunoprecipitation of the labeled IgA in NP-40 cell lysates at each time point (data not shown) . A small amount of ['H]leucine-labeled IgA was secreted in the presence of monensin (25% of control at 5 h), whereas secretion in the presence of CCCP was inhibited by >85% at all time points analyzed. Similar results have been reported previously for MOPC 315 IgA secretion (10) .
Analyses of the oligosaccharides obtained from a-chains that were pulse labeled with ['H]mannose for 20 min and then blocked intracellularly with CCCP or monensin are shown in Fig. 7 . Despite the presence of these inhibitors of secretion, no gross alterations of intracellular carbohydrate processing could be detected . The major oligosaccharide present after 3 h of chase eluted with the Man6GlcitolNAc standard regardless of whether the intracellular block occurred at the level of the rough endoplasmic reticulum (CCCP) or within the Golgi apparatus (monensin) . Thus, the removal of the first three a1,2-linked mannose residues occurs in the endoplasmic reticulum, since the time course for their removal is not affected by a CCCP-induced block of protein migration. In addition, the fact that the major oligosaccharide that accumulated in monensin-treated cells also has six mannose residues indicates that the final al,2-linked mannose residue is removed distal to the monensin block, and therefore in the trans Golgi complex. A small peak of radioactivity was identified in both CCCP-and monensin-treated cells that eluted with the standard Man5GIcitoINAc . However, no large accumulation of Man5GlcNAc 2 or smaller structures was ever observed . The major peak of radioactivity was identified as Man6GlcitolNAc even with chase periods of 5-6 h (data not shown) .
Characterization of the Oligosaccharides Containing Six Mannose Residues
Although the above data are compatible with two subcellular locations of a1,2-mannosidase activity involved in the processing of IgA secreted from MOPC 315 plasmacytoma 6F FIGURE 6 Effect of CCCP and monensin on the secretion of pulse-labeled IgA. MOPC 315 cells (7 . cells, this conclusion can only be made if the structures identified as Man6GlcitolNAc contain an al,2-linked mannose residue and if the mature, secreted oligosaccharides have been further processed to complex type structures. Purified Aspergillus satoi al,2-mannosidase therefore was used to characterize the Man6GlcitolNAc structures. This a-mannosidase releases only terminal al,2-linked mannose residues from carbohydrate structures (22, 23) . As seen in Fig. 8a , HPLC analysis shows that the major intracellular ['H]mannose-labeled oligosaccharide alcohol structure from pulselabeled a-chains chased for 5'/i h was Man6GlcitolNAc. Treatment of this sample with Aspergillus satoi a1,2-mannosidase before HPLC resulted in the formation of two different peaks of radioactivity, shown in Fig. 8b . The major peak had an elution profile that corresponded to that of the standard Man,GlcitoINAc, whereas the smaller peak eluted much earlier in a position that corresponded to mannose. The relative sizes of the radioactive peaks are consistent with the release of a single a1,2-linked mannose residue. Thus, the structure identified as Man6GlcitolNAc does contain an a1,2-linked mannose residue which, if further processing occurs, is removed at the time of secretion.
Determination of the Number of Mannose Residues in Secreted IgA a-Chain Oligosaccharides
The exact structures of the fully processed IgA carbohydrate chains are not known, but the secreted protein appears to have mainly complex-type oligosaccharides as determined by resistance to endo-ß-N-acetylglucosaminidase H (Fig. 1) . Typically, processing of complex-type oligosaccharides results in core structures containing only three mannose residueslinked to a chitobiose unit (24) . To determine the number of mannose residues present in the fully processed secreted molecule, we isolated and characterized [3H]mannose-labeled 315 IgA from the medium . Fig. 9a shows the gel filtration profile of the glycopeptides derived from secreted IgA . In contrast to their intracellular precursors, these structures have a higher apparent molecular weight, eluting near the void volume of the P-6 column. Treatment of these glycopeptides with endo-#-N-acetylglucosaminidase H released only a small amount of radioactivity (-10%, data not shown). The exact origin of these high-mannose structures is unknown . Nevertheless, most ofthe [3H]mannose-labeled, secreted IgA glycopeptides were resistant to endo-#-N-acetylglucosaminidase H. Fig. 9 b shows the P-6 gel filtration profile of these glycopeptides following sequential treatment with neuraminidase, #-galactosidase, and endo-#-N-acetylglucosaminidase . Two new peaks of radioactivity with lower apparent molecular weights could be identified suggesting that the secreted achains contain terminal monosaccharides other than mannose. Following exoglycosidase treatment, the oligosaccharides could be released from peptides by treatment with endo-#-N-acetylglucosaminidase D as judged by gel filtration on the P-6 column (Fig. 9c) . This endoglycosidase will cleave the chitobiose unit of complex-type oligosaccharides once the outer chain sugars are removed from the core structure Manal -3. 3 (Mana l -* 6)-Man# 1 -* 4G1cNAc#1 -+ 4G1cNAc --+ Asn. The a-mannose residue linked to the innermost #-linked mannose residue by a 1-3 linkage must be unsubstituted for enzymatic activity (25, 26) . Fig. 10 shows the HPLC analysis ofthe oligosaccharide alcohol derived from the major peak ofendo-#-N-acetylglucosaminidase D-released radioactivity. A large peak of radioactivity could be identified that had an elution profile identical to that of the standard Man3GlcitolNAc, indicating that complete processing to typical complex-type core structures does occur in the majority of IgA-associated oligosaccharides. Thus, the final a1,2-linked mannose residue is removed from the intracellular Man6GlcNAc 2 a-chain oligosaccharides as well as further processing to complex-type structures. As shown, these events occur rapidly at the time of secretion, since no large pools of partially processed oligosaccharides could be identified.
Characterization of Oligosaccharides on IgA aChains Secreted in the Presence of Monensin
As shown in Fig. 6, monensin inhibited ]mannose-labeled a-chain glycopeptides and oligosaccharides were analyzed by gel filtration on a Bio-Gel P-6 column as described in Fig . 2 . (A) the immunoprecipitated IgA containing [ 3 H]mannose-labeled a-chains was treated with pronase for 48 h and applied to the P-6 column ; (B) the major peak of radioactivity, indicated by the bar in A, was concentrated and treated sequentially with neuraminidase, #-galactosidase, and #-Nacetylglucosaminidase . A portion of the final digestion was applied directly to the P-6 column ; (C) following sequential treatment with exoglycosidases, the 1 3H]mannose-labeled glycopeptides were desalted and treated with endo-ß-N-acetylglucosaminidase D before applying to the P-6 column . The major peak of radioactivity was pooled as indicated by the bar, concentrated, reduced, and analyzed by HPLC . Vo and V100 indicate the elution positions of bovine serum albumin and mannose, respectively, determined in a separate experiment . HPLC analysis of secreted a-chain core oligosaccharides released by endo-,B-N-acetylglucosaminidase D .
['H]Mannose-labeled secreted IgA was treated with pronase and glycosidases as indicated in Fig. 9 . The major peak of radioactivity released by endo-ß-N-acetylglucosaminidase D, shown in Fig . 9 , panel C, was concentrated, reduced with sodium borohydride, and analyzed by HPLC as described in Fig. 3 . The bars labeled 2 through 7 indicate the elution volumes of the known ['H]mannose-labeled standards Man2_7 GIcito1NAc .
nose-labeled IgA was secreted in the presence of monensin relative to [3H]leucine-labeled IgA. As shown below, this is a result of incomplete oligosaccharide processing. Fig. 11 a shows a Bio-Gel P-6 gel filtration profile of the glycopeptides obtained after extensive pronase digestion . The elution profile was considerably different from that of IgA glycopeptides isolated from control cell secretions depicted in Fig. 9 a. In fact, the gel filtration elution profile was similar to that of glycopeptides derived from intracellular IgA (Fig. 2c) . Furthermore, a large proportion ofthe glycopeptides derived from IgA secreted in the presence of monensin were susceptible to endo-ß-N-acetylglucosaminidase H treatment, as determined by gel filtration (Fig. 11 b) . Analysis by HPLC of the endo-ß-N-acetylglucosaminidase H-released, reduced oligosaccharides revealed that they were similar in size to intracellular oligosaccharides present after several hours of chase incubation. Fig. 12 shows that the major oligosaccharide had an elution identical to that of the known standard Man6GlcitolNAc. Smaller amounts of Man5GlcitoINAc, Man7GIcitoINAc, and Man8GlcitoINAc were also identified. Free mannose and Man#GlcitoINAc were identified when these oligosaccharides were treated with jack bean a-mannosidase and analyzed by paper chromatography in solvent A, further showing that only mannose and GlcitolNAc were present (data not shown) .
Recent investigations have elucidated the steps involved in the formation of complex-type N-linked asparagine oligosaccharides (1) . Following the transfer of GIc3Man9GlcNAc2 from dolichol diphosphate to proteins, the glucose residues are rapidly removed by glucosidases located in the rough and smooth endoplasmic reticulum. This investigation has focused on the subsequent removal of the four al,2-linked mannose residues, which is the next major stage ofprocessing involved in the formation ofcomplex-type N-linked oligosaccharides. Enzymes capable ofspecifically cleaving a 1,2-linked mannose residues from high mannose substrates have been partially purified from mammalian tissues (5, 6, 13, 27) . Since 41 4 THE JOURNAL OF CELL BIOLOGY -VOLUME 98, 1984 several ofthese have been isolated from rat Golgi membrane preparations, it has been speculated that the Golgi complex is the subcellular site for this processing step (5, 6) . However, others have presented evidence to indicate that the rough FIGURE 11 Gel filtration of f H]mannose-labeled a-chain glycopeptides and oligosaccharides secreted in the presence of monensin . MOPC 315 cells were pulse-labeled for 20 min with [3H]-mannose and chased in nonradioactive medium containing monensin (10 1AM) . After 5 1/2 h, the secreted IgA was immunoprecipitated from the medium . Following the enzyme treatments indicated, the [ 3 H]mannose-labeled a-chain glycopeptides and oligosaccharides were analyzed by gel filtration on a Bio-Gel P-6 column as described in Fig. 2 . A, the immunoprecipitated IgA containing [ 3 H]mannoselabeled a-chains was treated with pronase for 48 h . A portion of the digestion was applied to the P-6 column . B, pronase digested glycopeptides were treated with endo-ß-N-acetylglucosaminidase H for 18 h and applied to the P-6 column . Fractions 105 to 122 containing released oligosaccharides were pooled, concentrated, reduced with sodium borohydride, and analyzed by HPLC . Vo and V100 indicate the elution of bovine serum albumin and mannose, respectively, determined in a separate experiment . endoplasmic reticulum is a major site of a1,2-mannosidase activity (9, (11) (12) (13) .
Our data indicate that there is al,2-mannosidase activity in the rough endoplasmic reticulum of MOPC 315 cells . The pulse-chase experiments show that, despite the long intracellular half-life of IgA a-chains, processing of the first three a1,2-linked mannose residues occurs soon after the highmannose oligosaccharide is transferred to this protein. The use of CCCP, an inhibitor of protein migration in the rough endoplasmic reticulum, provided further evidence to define the subcellular location ofprocessing a1,2-mannosidase activity . The time course for the removal of the first three al,2-linked mannose residues was not affected by a CCCP-induced block, consistent with mannosidase activity in the rough endoplasmic reticulum.
The extent of endoplasmic reticulum a1,2-mannosidase processing ofa-chains in MOPC 315 cells is somewhat different from that observe for other proteins in other cell types. Tartakoff and Vassalli (9) suggested that the mannose trimming of newly synthesized A-chains in murine plasmablasts occurred in the rough endoplasmic reticulum . However, structural analyses were not performed to document the exact extent of processing. Godaleine et al. (11) have reported processing a1,2-mannosidase activity in both the endoplasmic reticulum and Golgi apparatus of calf thyroid cells. They found that a single a1,2-linked mannose residue was removed from thyroglobulin in the endoplasmic reticulum . . Likewise, Hakimi and Atkinson (12) concluded that one mannose residue was removed from Sindbis virus proteins B and PE2 in the rough endoplasmic reticulum of chick embryo fibroblasts. Our evidence that a1,2-mannosidase activity is in the rough endoplasmic reticulum is consistent with those described above. However, three al,2-linked mannose residues ofnewly synthesized MOPC 315 a-chain oligosaccharides are removed in the endoplasmic reticulum . Compared with the other studies, this difference may be a result of the particular glycoprotein studied since our investigation does not exclude the presence of a1,2-mannosidase activity in the early or cis Golgi apparatus of MOPC 315 plasmacytoma cells. Indeed, the extent of a1,2-mannosidase processing in any subcellular location may depend on the individual protein. It may be that the relatively slow secretory rate ofthe a-chains lengthens the time of their exposure to endoplasmic reticulum al,2-mannosidase, resulting in the formation of Man6GlcNAc2 oligosaccharides.
Of interest was the time course for the removal of the final a1,2-linked mannose residue from the IgA a-chains . Processing of the oligosaccharides containing six mannose residues to complex-type structures occurred rapidly at the time of secretion, since no oligosaccharides containing five or less mannose residues could be isolated from cells during long chase incubations. Thus, this al,2-mannosidase activity is associated with the subsequent processing enzymes known to be located in the trans Golgi apparatus (20, 21) . The results obtained from the experiments using monensin are consistent with the presence of al,2-mannosidase in this subcellular location. Recent studies have indicated that the site of action of monensin is between the cis and trans Golgi elements (20, 21, 28) , although evidence for a block beyond the Golgi apparatus has also been proposed (29) . In the presence of monensin, the major a-chain oligosaccharide isolated from the cells and medium contained six mannose residues . Therefore, al,2-mannosidase activity that can remove the final a 1,2-linked mannose residue is located beyond the monensininduced block . We cannot exclude the possibility that some a1,2-mannosidase activity responsible for the removal ofthe final a1,2-linked mannose exists before the monensin block since very small, but measurable, amounts of Man5GlcNAc were isolated from cells treated with either monensin or CCCP (Fig. 7) and from the medium of cells treated with monensin (Fig. 12) . Nevertheless, appreciable amounts ofMansGlcNAc2 a-chain oligosaccharides were not identified after long incubations in the presence of these inhibitors . This, plus the pulse-chase experiments depicting an association of the removal ofthe final a1,2-linked mannose residue with enzymes responsible for subsequent carbohydrate processing, provides strong evidence for the presence of a 1,2-mannosidase activity in the trans Golgi apparatus . Processing a1,2-mannosidase in this Golgi subcompartment has not been characterized extensively. In fact, there have been conflicting reports as to whether a1,2-mannosidase activity exists in the cis or trans Golgi apparatus (30) (31) (32) . These studies have involved subcellular fractionation of various cell types. However, the documentation ofa 1,2-mannosidase activity in various subcellular fractions may well require specific substrates. For example, we have recently determined that the structure of the intracellular IgA oligosaccharides containing six mannose residues is a single species with the a1,2-linked mannose residue present on the mannose-linked a 1,3 to the innermost ß-linked core mannose residue (data not shown) . This suggests that the purported MOPC 315 trans Golgi a1,2-mannosidase is specific. If so, it would be necessary to have a Man6-substrate containing a single specific a1,24inked mannose residue in order to detect enzymatic activity in the trans Golgi apparatus of these cells. Such an oligosaccharide used as a substrate would be ideal for detecting the trans Golgi apparatus a1,2-mannosidase activity but may well be a poor substrate for rough endoplasmic reticulum or cis Golgi a 1,2-mannosidases. Likewise, a substrate containing eight mannose residues might be a poor substrate for a trans Golgi a1,2-mannosidase . We are currently investigating this hypothesis using a number of well characterized ['H]mannose-labeled substrates.
It is not know whether a trans Golgi apparatus a1,2 mannosidase that specifically removes the last a1,2-linked mannose residue from Man6GlcNAc2 is present in all cell types. Preliminary data have indicated the presence of such an enzyme in MOPC 460 cells, another murine IgA-secreting plasmacytoma cell line. Likewise, Ruddon et al. (19) using cultured human choriocarcinoma cells have shown that pulselabeled a-subunits of human chorionic gonadotropin have a relatively long intracellular half-life and contain oligosaccharides that remain sensitive to endo-O-N-acetylglucosaminidase H until secreted . Furthermore, a major a-subunit oligosaccharide species accumulating intracellularly appeared to be Man6GlcNAc2, a result similar to our findings with the achain of MOPC 315 IgA. Both human chorionic gonadotropin and IgA are secretory proteins known to be secreted continuously without appreciable intracellular storage. Whether this pattern of a1,2-linked mannose processing is unique to secreted glycoproteins remains to be verified .
The removal of the final a1,2-linked mannose residue and subsequent carbohydrate modifications do not appear to be absolute requirements for the secretion of IgA since even in the presence of monensin, some a-chains with partially processed high mannose-type oligosaccharides are secreted . Recently, it has also been shown that monensin treatment of human fibroblasts in culture results in the secretion of fibronectin with abnormal carbohydrate chains (33) . Our study clearly demonstrates that the initial carbohydrate-processing events are not affected by monensin, as the glucose residues are rapidly removed and the time course for the removal of the first three a1,24inked mannose residues is unchanged. However, a-chains secreted in the presence of monensin have carbohydrate structures similar to those accumulating intracellularly . Whether monensin directly inhibits the processing enzymes in the trans Golgi apparatus or in some way causes the partially processed a-chains to bypass this site leading to secretion by another subcellular route remains to be elucidated.
We conclude that the processing of MOPC 315 IgA a-chain oligosaccharides involves the activity of a1,2-mannosidase in at least two subcellular locations. This may represent the presence of several enzyme proteins as have been described in rat liver (5, 6) . To date, we do not have direct evidence for the presence of multiple al,2-mannosidase enzymes in MOPC 315 cells. It is possible that a single enzyme protein exists within the endoplasmic reticulum and Golgi apparatus. Various changes in the subcellular environment might affect substrate-enzyme interactions, resulting in preferential hydrolysis of mannose residues from a specific oligosaccharide structure. Although we believe that this is unlikely, direct evidence must await isolation and characterization of the proteins responsible for the a1,2-mannosidase activities demonstrated in this study.
